Diffusion-Weighted MRI for Nodal Staging of Head and Neck Squamous Cell Carcinoma: Impact on Radiotherapy Planning

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 761-766

  Dirix, Piet ^a   Vandecaveye, Vincent ^a   De Keyzer, Frederik ^a   Op de beeck, Katya ^a   Poorten, Vincent Vander ^a   Delaere, Pierre ^a   Verbeken, Eric ^a   Hermans, Robert ^a   Nuyts, Sandra ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Head and neck cancer; MRI; Nodal staging; Radiotherapy

Indexed keywords

ABSOLUTE DIFFERENCE; CLINICAL TARGET VOLUMES; COMPUTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTRAST-ENHANCED; CONVENTIONAL IMAGING; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; DIFFUSION-WEIGHTED MRI; GROSS TUMOR VOLUME; HEAD AND NECK CANCER; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; IMAGING MODALITY; IMMUNOSTAINING; LYMPH NODE; MCNEMAR; MRI IMAGE; POTENTIAL IMPACTS; RADIOTHERAPY PLANNING; REFERENCE SET; TARGET VOLUMES; TUMOR CONTROL; WILCOXON TEST;

BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; MAGNETIC RESONANCE IMAGING; PARTICLE DETECTORS; PATHOLOGY; RADIOTHERAPY; RESONANCE; TUMORS;

DIELECTRIC WAVEGUIDES;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; DIFFUSION WEIGHTED IMAGING; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MCNEMAR TEST; NECK DISSECTION; PATHOLOGY; PRIORITY JOURNAL; RANK SUM TEST; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TOPOGRAPHY; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KERATINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76049121036     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.068     Document Type: Article

References (32)

1. Nuyts S., Dirix P., Clement P.M.J., et al. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 73 (2009) 1088-1095
2. Veldeman L., Madani I., Hulstaert F., et al. Evidence behind use of intensity-modulated radiotherapy: A systematic review of comparative clinical studies. Lancet Oncol 9 4 (2008) 367-375
3. Daisne J.-F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging and FDG-PET and validation with surgical specimen. Radiology 233 (2004) 93-100
4. de Bondt R.B., Nelemans P.J., Hofman P.A., et al. Detection of lymph node metastases in head and neck cancer: A meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64 (2007) 266-272
5. Adams S., Baum R.P., Stuckensen T., Bitter K., and Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 (1998) 1255-1260
6. Hannah A., Scott A.M., Tochon-Danguy H., et al. Evaluation of 18F-FDG PET and CT with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 236 (2002) 208-217
7. Ng S.-H., Yen T.-C., Liao C.-T., et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: A prospective study of 124 patients with histologic correlation. J Nucl Med 46 (2005) 1136-1143
8. Schwartz D.L., Ford E., Rajendran J., et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 129-136
9. Jeong H.-S., Baek C.-H., Son Y.-I., et al. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 29 (2007) 203-210
10. Fleming A.J., Smith S.P., Paul C.M., et al. Impact of 18F-FDG PET/CT on previously untreated head and neck cancer patients. Laryngoscope 117 (2007) 1173-1179
11. Murakami R., Uozumi H., Hirai T., et al. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 68 (2007) 377-382
12. Le Bihan D. Molecular diffusion, tissue microdynamics and -microstructure. NMR Biomed 8 (1995) 375-386
13. Vandecaveye V., De Keyzer F., Nuyts S., et al. Detection of head and neck squamous cell carcinoma with DW-MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67 (2007) 960-971
14. Abdel Razek A.A., Kandeel A.Y., Soliman N., et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and post-treatment changes. AJNR Am J Neuroradiol 28 (2007) 1146-1152
15. Sumi M., Sakihama N., Sumi T., et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 24 (2003) 1627-1634
16. Abdel Razek A.A., Soliman N.Y., Elkhamary S., Alsharaway M.K., and Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 16 (2006) 1468-1477
17. King A.D., Ahuja A.T., Yeung D.K.W., et al. Malignant cervical lymphadenopathy: Diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245 (2007) 806-813
18. Vandecaveye V., De Keyzer F., Vander Poorten V., et al. Value of diffusion-weighted MRI for nodal staging in head and neck squamous cell carcinoma. Radiology 251 (2009) 134-146
19. Robbins K.T., Medina J.E., Wolfe G.T., et al. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117 (1991) 601-605
20. Castelijns J.A. van den Brekel MW. Imaging of lymphadenopathy in the neck. Eur Radiol 12 (2002) 727-738
21. Hermans R., Op de beeck K., Van den Bogaert W., et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 50 (2001) 37-45
22. Chao K.S.C., Wippold F.J., Ozyigit G., Tran B.N., and Dempsey J.F. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53 (2002) 1174-1184
23. Eisbruch A., and Foote R.L. O'Sullivan B, Beitler JJ, Vikram B. Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12 (2002) 238-249
24. Bussels B., Maes A., Hermans R., et al. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 72 (2004) 119-127
25. Grégoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
26. Grégoire V., Eisbruch A., Hamoir M., and Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79 (2006) 15-20
27. van den Brekel M.W., van der Waal I., Meijer C.J., et al. The incidence of micrometastases in neck dissection specimens obtained form elective neck dissections. Laryngoscope 106 (1996) 987-991
28. Haraf D.J., Rosen F.R., and Stenson K. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 9 16 (2003) 5936-5943
29. Schwartz D.L., Ford E.C., Rajendran J., et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck 27 (2005) 478-487
30. Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68 11 (2007) 126-135
31. Lee N.Y., Mechalakos J.G., Nehmeh S., et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: A feasibility study. Int J Radiat Oncol Biol Phys 70 1 (2008) 2-13
32. Grégoire V., Bol A., Geets X., and Lee J. Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol 16 4 (2006) 232-238